Filing Details
- Accession Number:
- 0001209191-20-055013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-16 12:14:38
- Reporting Period:
- 2020-10-14
- Accepted Time:
- 2020-10-16 12:14:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1683553 | Spruce Biosciences Inc. | SPRB | Pharmaceutical Preparations (2834) | 812154263 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1822418 | Dina Moghrabi Chaya | C/O Omega Fund Management, Llc 888 Boylston St., Suite 1111 Boston MA 02199 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-10-14 | 1,911,022 | $0.00 | 1,911,022 | No | 4 | C | Indirect | See Footnotes |
| Common Stock | Acquisiton | 2020-10-14 | 250,000 | $15.00 | 2,161,022 | No | 4 | P | Indirect | See Footnotes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | See Footnotes |
| No | 4 | P | Indirect | See Footnotes |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series B Preferred Stock | Disposition | 2020-10-14 | 12,500,000 | $0.00 | 1,911,022 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect |
Footnotes
- Each share of Series B Preferred Stock automatically converted into 0.152881822351322 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering on October 14, 2020 (on an adjusted basis, after giving effect to the 1-for-6.541 reverse stock split of the common stock effected by the Issuer on October 2, 2020) The shares have no expiration date.
- Consists of 1,911,022 shares beneficially owned by Omega Fund VI, L.P.
- The Reporting Person, a Director of the Issuer, is an advisor at Omega Fund Management, LLC, an entity affiliated with Omega Fund VI, L.P.and disclaims beneficial ownership of the shares held by Omega Fund VI, L.P., except to the extent of her pecuniary interest therein.
- The shares were purchased in the Issuer's initial public offering.
Billionaire Hedge Funds
